The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT01707992 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2199

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Laquinimod
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.